The 8 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 7.50, with a high estimate of 15.00 and a low estimate of 6.00. The median estimate represents a +9.49% increase from the last price of 6.85.
The current consensus among 9 polled investment analysts is to Hold stock in Puma Biotechnology Inc. This rating has held steady since August, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.29
Reporting Date Nov 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.